This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
in one of the most closely watched biotechnology cases in recent years. In 2014, another biotechnology company sought billions of dollars in damages and a permanent injunction against the sale of Sanofi and Regeneron's lifesaving and cholesterol-reducing drug Praluent over patent disputes.
For instance, a 2014 study cited in the current paper by Mayfield and his team found that algae can produce 167 times more useful biomass than corn annually while using the same amount of land.
and its subsidiary, AbbVie Biotechnology, Ltd. The allegations in both cases focus on Facebook's 2012 purchase of Instagram, its 2014 purchase of WhatsApp, and a range of allegedly anticompetitive conditions that Facebook imposes on third parties seeking to access its platform. The complaint alleged that AbbVie Inc. Facebook, Inc. ,
We organize all of the trending information in your field so you don't have to. Join 12,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
52 
Let's personalize your content